Katherine A. Eade Harvard Bioscience Inc (HBIO) insider trading activity

HBIO Quotes by TradingView

Katherine A. Eade is Director of HARVARD BIOSCIENCE INC. Currently has a direct ownership of 311,126 shares of HBIO, which is worth approximately $731,146. The most recent transaction as insider was on May 21, 2024, when has been sold 45,872 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 311K
0% 3M change
17.29% 12M change
Total Value Held $731,146

Katherine A. Eade Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2024
BUY
Grant, award, or other acquisition
-
45,872 Added 12.85%
311,126 Common Stock
May 22 2023
BUY
Grant, award, or other acquisition
-
25,554 Added 8.79%
265,254 Common Stock
May 24 2022
BUY
Grant, award, or other acquisition
-
38,259 Added 13.76%
239,700 Common Stock
Jan 01 2022
BUY
Grant, award, or other acquisition
-
2,525 Added 1.24%
201,441 Common Stock
Dec 28 2021
BUY
Grant, award, or other acquisition
-
1,401 Added 0.7%
198,916 Common Stock
May 25 2021
BUY
Grant, award, or other acquisition
-
14,400 Added 6.8%
197,515 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
-
14,200 Added 7.2%
183,115 Common Stock

Also insider at

VAXX
Vaxxinity, Inc. Healthcare
Director
KAE

Katherine A. Eade

Director
Holliston, MA

Track Institutional and Insider Activities on HBIO

Follow HARVARD BIOSCIENCE INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HBIO shares.

Notify only if

Insider Trading

Get notified when an Harvard Bioscience Inc insider buys or sells HBIO shares.

Notify only if

News

Receive news related to HARVARD BIOSCIENCE INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HBIO